-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QoPGx7uO5pRH604UvCvjzc6X+NUXMAD8SBjpBvA3ZxjXJJw8mjRmqIbvBl2017Iu iN3HHXRcbRjFlQfWJ2oJGg== 0001140361-09-008658.txt : 20090401 0001140361-09-008658.hdr.sgml : 20090401 20090401172048 ACCESSION NUMBER: 0001140361-09-008658 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20090401 DATE AS OF CHANGE: 20090401 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ADELMAN JASON T CENTRAL INDEX KEY: 0001247604 FILING VALUES: FORM TYPE: SC 13G/A MAIL ADDRESS: STREET 1: 900 PARK AVENUE STREET 2: APARTMENT 15A CITY: NEW YORK STATE: NY ZIP: 10021 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ADVENTRX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001160308 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841318182 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-78541 FILM NUMBER: 09724469 BUSINESS ADDRESS: STREET 1: 6725 MESA RIDGE ROAD STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92131 BUSINESS PHONE: 8585520866 MAIL ADDRESS: STREET 1: 6725 MESA RIDGE ROAD STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92131 FORMER COMPANY: FORMER CONFORMED NAME: BIOKEYS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20010928 SC 13G/A 1 doc1.htm Schedule 13G

United States
Securities and Exchange Commission
Washington, D.C. 20549

Schedule 13G

Under the Securities Exchange Act of 1934
(Amendment No. 01)*

OMB Number
3235-0145
ADVENTRX PHARMACEUTICALS INC
(Name of Issuer)
Common Stock
(Title of Class of Securities)
00764X103
(CUSIP Number)
March 30, 2009
(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

  Rule 13d-1(b)
√ Rule 13d-1(c)
  Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No.

  1. Names of Reporting Persons.
    I.R.S. Identification Nos. of above persons (entities only).

    ADELMAN JASON T

  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    1.  
    2.  
  3. SEC Use Only
  4. Citizenship or Place of Organization

    United States

Number of Shares Beneficially Owned by Each Reporting Person With:

  1. Sole Voting Power

    4,400,000

  2. Shared Voting Power

  3. Sole Dispositive Power

    4,400,000

  4. Shared Dispositive Power

  1. Aggregate Amount Beneficially Owned by Each Reporting Person

    4,400,000

  2. Check if the Aggregate Amount in Row 9 Excludes Certain Shares (See Instructions)    
  3. Percent of Class Represented by Amount in Row 9

    4.875

  4. Type of Reporting Person (See Instructions)

    IN

Footnotes:

Shares are held in joint tenancy with right of survivorship with Reporting Person's spouse.

 

Item 1.

  1. Name of Issuer

    Adventrx Pharmaceuticals Preparations, Inc.

  2. Address of Issuer's Principal Executive Offices

    6725 MESA RIDGE ROAD
    SUITE 100
    SAN DIEGO CA 92131

Item 2.

  1. Name of Person Filing

    Jason T. Adelman

  2. Address of Principal Business Office or, if None, Residence

    590 Madison Avenue
    Fifth Floor
    New York, NY 10022

  3. Citizenship

    United States

  4. Title of Class of Securities

    Common Stock

  5. CUSIP Number

    00764X103

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

  1.    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
  2.    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
  3.    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
  4.    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).
  5.    An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
  6.    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
  7.    A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
  8.    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
  9.    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
  10.    Group, in accordance with §240.13d-1(b)(1)(ii)(J).

Item 4. Ownership

  1. Amount beneficially owned:

    4,400,000

  2. Percent of class:

    4.875

  3. Number of shares as to which the person has:
    1. Sole power to vote or to direct the vote:

      4,400,000

    2. Shared power to vote or to direct the vote:

    3. Sole power to dispose or to direct the disposition of:

      4,400,000

    4. Shared power to dispose or to direct the disposition of:

Item 5. Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following  √ .

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

 

Item 8. Identification and Classification of Members of the Group

 

Item 9. Notice of Dissolution of Group

 

Item 10. Certification

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

April 01, 2009
Date
/s/ Jason T. Adelman
Signature
Jason T. Adelman
Name / Title

NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties for whom copies are to be sent.

Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)

Footnotes:

Shares are held in joint tenancy with right of survivorship with Reporting Person's spouse.

 -----END PRIVACY-ENHANCED MESSAGE-----